Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1995-06-06
1998-11-10
Tsang, Cecilia J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 15, 530316, 530327, 530328, A61K 3800
Patent
active
058344322
ABSTRACT:
Angiotensin II Type 2 receptor agonists (AT2 receptor subtype agonists) are useful in accelerating wound healing. These compounds form the basis of compositions useful for accelerating wound healing, in which the active agent is present in an amount effective to accelerate wound healing. Preferably, the compositions are in the form of matrical or micellar solutions.
REFERENCES:
patent: 5015629 (1991-05-01), di Zerega
Hunt et al., Coagulation and macrophage stimulation of angiogenesis and wound healing, in The surgical wound, pp. 1-18, ed. F. Dineen & G. Hildrick-Smith (Lea & Febiger, Philadelphia: 1981).
Grotendorst, GR et al. (1985) Stimulation of granulation tissue formation by platelet-derived growth factor in normal and diabetic rats. J Clin Invest 76:2323-9.
Mustoe, TA et al. (1987) Accelerated healing of incisional wounds in rats induced by transforming growth factor-.beta.. Science 237:1333-5.
Pierce, GF et al. (1988) In vivo incisional wound healing agumented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med 167:974-87.
Lynch, SE et al. (1989) Growth factors in wound healing. J Clin Invest 84:640-6.
Greenhalgh, DG et al. (1990) PDGF and FGF stimulate wound healing in the genetically diabetic mouse. Am J Pathol 136:1235-46.
Kimura et al. Changes in skin angiotensin II receptors in rats during wound healing. Biochem Biophys Res Commun 187:1083-90, 1992.
Speth, RC ad KH Kim. 1990. Discrimination of two angiotensin II receptor subtypes with a selective agonist analogue of angiotensin II, p-amnophenylalanine6 angiotensin II. Biochem Biophys Res Commun 169:997-1006.
Catalioto et al. 1994. Angiotensins induce the release of prostacyclin from rabbit vas deferens: evidence for receptor heterogeneity. Eur J Pharmacol 256:93-97.
Bryson, SE et al. 1992. Induction of the angiotensin At2 receptor subtype expression by differentiation of the neuroblastoma x glioma hybrid, NG-108-15. Eur J Pharmacol 225:119-127.
Dzau V.E. et al. (1989) Molecular mechanism of angiotensin in the regulation of vascular and cardiac growth. J Mol Cell Cardiol 21 (Supple III):S7.
Berk, BC et al. (1989) Angiotenin II stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 13:305-14.
Kawahara, Y, et al. (1988) Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells. BBRC 150:52-9.
Naftilan, AJ et al. (1989) Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest 83:1419-24.
Taubman, MB et al. (1989) Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca.sup.2+ mobilization and protein kinase C activation. J Biol Chem 264:526-530.
Nakahara, K et al. (1992) Identification of three types of PDGF-A chain gene transcripts in rabbit vascular smooth muscle and their regulated expression during development and by angiotensin II. BBRC 184:811-8.
Stouffer GA and GK Owens. (1992) Angiotensin II induced mitogenesis of spontaneously hypertensive rat derived cultured smooth muslce cells is dependent on autocrine production of transforming growth factor-.beta.. Circ Res 70:820-828.
Wolf, G et al. (1992) Angiotensin II stimulates the proliferation and biosynthesis of type I collagen in cultured murine mesangial cells. Am J Pathol 140:95-107.
Bell, L and JA Madri (1990) Influence of the angiotensin system on endothelial and smooth muscle cell migration. Am J Pathol 137:7-12.
Fernandez, LA et al. (1985) Neovascularization produced by angiotensin II. J Lab Clin Med 105:141.
LeNoble, FAC et al. (1991) Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur J Pharmacol 195:305-6.
Powell, JS et al. (1989) Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 245:186-8.
Powell, JS et al. (1991) The proliferative response to vascular injury is suppressed by converting enzyme inhibition. J Cardiovasc Pharmacol 16 (suppl 4):42-9.
Capron, L et al. (1991) Effect of ramipril, an inhibitor of angiotensin converting enzyme, on the response of rat thoracic aorta to injury with a balloon catheter. J Cardiovasc Pharmacol 18:207-11.
Osterrieder, W. et al. (1991) Role of angiotensin II injury-induced neointima formation in rats. Hypertension 18:Suppl II60-64.
Daemen, MJAP et al. (1991) Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res 68:450-6.
Schelling, P et al. (1979) Effects of angiotensin II and angiotensin II antagonist saralysin on cell growth and renin in 3T3 and SV3T3 cells. J Cell Physiol 98:503-13.
Campbell-Boswell, M and AL Robertson. (1981) Effects of angiotensin II and vasopressin on human sooth muscle cells in vitro. Exp Mol Pathol 35:265-76.
Emmett, N et al. (1986) Effect of saralasin (angiotensin II antagonist) on 3T3 cell growth and proliferation. J Cell Biol 103:171 (Abst).
Paquet, JL et al. (1990) Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens 8:565-72.
Geisterfer, AAT et al. (1988) Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62:749-56.
Naftilan, AJ (1992) The role of angiotensin II in vascular smooth muscle cell growth. J Cardiovas Pharmacol 20:S37-40.
Gibbons, GH et al. (1992) Vascular smooth muscle cell hypertrophy vs hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest 90:456-61.
Bell, L et al. (1992) Autocrine angiotensin system regulation of bovine aortic endothelial cell migration and plasminogen activator involves modulation of proto-oncogene pp60c-src expression. J Clin Invest 89:315-20.
Berk, BC and GN Rao. (1993) Angiotensin II-induced vascular smooth muscle cell hypertrophy: PDGF A-chain mediates the increase in size. J Cell Physiol 154:368-80.
Wolf, G et al. (1991) Intracellular signalling of transcription and secretion of type IV collagen after angiotensin II-induced cellular hypertrophy in cultured proximal tubular cells. Cell Reg 2:219-27.
Zhou, G et al. (1992) Antiotensin II mediated stimulation of collagen synthesis in cultured cardiac fibroblasts. FASEB J 6:A1914.
Kimura, B et al. (1992) Changes in skin angiotensin II receptors in rats during wound healing. BBRC 187:1083-1090.
Phillips et al. 1994. Angiotensin receptor stimulation of transforming growth factor-.beta. in rat skin and wound healing. In Angiotensin Receptors (ed JM Saavedra and PBMWM Timmermans), Plenum Press, New York, NY, pp. 377-396.
Wong, PC. 1994. Angiotensin antagonists in models of hypertension. In: Angiotensin Receptors (JM Saavedra and PBMWM Timmermans), Plenum Press NY, NY pp. 319-336.
MacKenzie et al. 1994. TCV 116 prevents progressive renal injury in rats with extensive renal ablation. J. Hypertension 12 (Suppl 9):S11-S16.
Gupta, et al. 1995. Locally generated angiotensin II in the adrenal gland regulates basal, corticotropin and potassium-stimulaed aldosterone secretion. Hypertension 25:443-448.
Lloren-Cortes, et al. 1994. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension 24:538-548.
Pratt, RE et al. 1992. The AT2 isoforms of the angiotensin receptor mediates myointimal hyperplasia following vascular injury. Hypertension 20:432.
Viswanathan, M et al. Balloon angioplasty enhances the expression of angiotensin II subtype AT1 receptors in the neointima of rat aorta. J Clin Invest 90:1707-12, 1992.
Viswanathan, M, and JM Saavedra (1992) Expressin of Angiotensin II AT.sub.2 Receptors in the Rat Skin During Experimental Wound Healing. Peptides 13:783-6.
Janiak et al. 1992. Role of angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension 20:737-45.
Forney Prescott et al. 1991. Angiotensin-converting enzyme inhibitor versus angiotensin II, AT1 receptor antagonist.
diZerega Gere Stodder
Rodgers Kathleen Elizabeth
Delacroix-Muirheid C.
The University of Southern California
Tsang Cecilia J.
LandOfFree
Use of angiotensin II Type 2 receptor agonists in tissue repair does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of angiotensin II Type 2 receptor agonists in tissue repair, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of angiotensin II Type 2 receptor agonists in tissue repair will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1516753